Serum DIDO1-Ab and FOXJ2-Ab levels were significantly higher in patients with rheumatoid arthritis and SLE (but not in those with Sjögren’s syndrome or ulcerative colitis) than in HDs (Supplementary Table S2). This evidence concerns the gene DIDO1 and rheumatoid arthritis.